FDA Approved: QUESTRAN — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for QUESTRAN (cholestyramine) from Endo USA, Inc., updating its labeling to reflect additional indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis
• Diarrhea Due to Bile Acid Malabsorption
• Hypercholesterolemia

Drugs mentioned

• QUESTRAN (Cholestyramine)

Snippet

SUPPL AP for QUESTRAN (CHOLESTYRAMINE)